Keratinocyte growth factor gene transduction ameliorates pulmonary fibrosis induced by bleomycin in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 3, 2011, Pages 489-497

  Sakamoto, Seiko ^a   Yazawa, Takuya ^a   Baba, Yasuko ^a   Sato, Hanako ^a   Kanegae, Yumi ^b   Hirai, Toyohiro ^c   Saito, Izumu ^b   Goto, Takahisa ^a   Kurahashi, Kiyoyasu ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adenovirus; Gene therapy; Keratinocyte growth factor; Pulmonary fibrosis

Indexed keywords

ADENOVIRUS VECTOR; BLEOMYCIN; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; SODIUM CHLORIDE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MEGADOSE; GENE THERAPY; GENETIC TRANSDUCTION; HISTOPATHOLOGY; LOW DRUG DOSE; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MORTALITY; MOUSE; NONHUMAN; OSMOTIC PUMP; PHENOTYPE; PLEURAL FIBROSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADENOVIRIDAE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 7; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RNA, MESSENGER; SURFACE-ACTIVE AGENTS; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRIDAE; MUS;

EID: 80052548516     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0092OC     Document Type: Article

References (29)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
2. Selman M., King T.E., Pardo A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
3. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-529. (Pubitemid 46348506)
4. Davis H.L. Jr, Von Hoff D.D., Henney J.E., Rozencweig M. The role of antitumor antibiotics in current oncologic practice. Cancer Chemother Pharmacol 1978;1:83-90. (Pubitemid 9225235)
5. Blum R.H., Carter S.K., Agre K. A clinical review of bleomycin: A new antineoplastic agent. Cancer 1973;31:903-914.
6. Adamson I.Y., Bowden D.H. The pathogenesis of bloemycin-induced pulmonary fibrosis in mice. Am J Pathol 1974;77:185-197.
7. Sikic B.I., Young D.M., Mimnaugh E.G., Gram T.E. Quantification of bleomycin pulmonary toxicity in mice by changes in lung hydroxyproline content and morphometric histopathology. Cancer Res 1978;38:787-792. (Pubitemid 8319559)
8. Rubin J.S., Osada H., Finch P.W., Taylor W.G., Rudikoff S., Aaronson S.A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989;86:802-806. (Pubitemid 19056244)
9. Fehrenbach H., Kasper M., Tschernig T., Pan T., Schuh D., Shannon J.M., Muller M., Mason R.J. Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. Eur Respir J 1999;14:534-544. (Pubitemid 29479716)
10. Xu X., McCormick-Shannon K., Voelker D.R., Mason R.J. KGF increases SP-A and SP-D mRNA levels and secretion in cultured rat alveolar type II cells. Am J Respir Cell Mol Biol 1998;18:168-178. (Pubitemid 128355190)
11. Ware L.B., Matthay M.A. Keratinocyte and hepatocyte growth factors in the lung: Roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002;282:L924-L940. (Pubitemid 34654608)
12. Bao S., Wang Y., Sweeney P., Chaudhuri A., Doseff A.I., Marsh C.B., Knoell D.L. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005;288:L36-L42. (Pubitemid 40023884)
13. Barazzone C., Donati Y.R., Rochat A.F., Vesin C., Kan C.D., Pache J.C., Piguet P.F. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol 1999;154:1479-1487. (Pubitemid 29226443)
14. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358. (Pubitemid 30408720)
15. Lu Y., Pan Z.Z., Devaux Y., Ray P. p21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor-mediated inhibition of oxidant-induced cell death. J Biol Chem 2003;278:10374-10380. (Pubitemid 36800301)
16. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X.F., Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci USA 2003;100:6098-6103. (Pubitemid 36576937)
17. Takeoka M., Ward W.F., Pollack H., Kamp D.W., Panos R.J. KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 1997;272:L1174-L1180.
18. Panos R.J., Bak P.M., Simonet W.S., Rubin J.S., Smith L.J. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest 1995;96:2026-2033.
19. Sugahara K., Iyama K., Kuroda M.J., Sano K. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J Pathol 1998;186:90-98. (Pubitemid 28407493)
20. Yi E.S., Williams S.T., Lee H., Malicki D.M., Chin E.M., Yin S., Tarpley J., Ulich T.R. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol 1996;149:1963-1970. (Pubitemid 26415215)
21. Deterding R.R., Havill A.M., Yano T., Middleton S.C., Jacoby C.R., Shannon J.M., Simonet W.S., Mason R.J. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Assoc Am Physicians 1997;109:254-268. (Pubitemid 27209032)
22. Baba Y., Yazawa T., Kanegae Y., Sakamoto S., Saito I., Morimura N., Goto T., Yamada Y., Kurahashi K. Keratinocyte growth factor gene transduction ameliorates acute lung injury and mortality in mice. Hum Gene Ther 2007;18:130-141. (Pubitemid 46446050)
23. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-199.
24. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93:1320-1324.
25. Ashcroft T., Simpson J.M., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988;41:467-470. (Pubitemid 18098428)
26. Kalina M., Mason R.J., Shannon J.M. Surfactant protein C is expressed in alveolar type II cells but not in Clara cells of rat lung. Am J Respir Cell Mol Biol 1992;6:594-600.
27. Morikawa O., Walker T.A., Nielsen L.D., Pan T., Cook J.L., Mason R.J. Effect of adenovector-mediated gene transfer of keratinocyte growth factor on the proliferation of alveolar type II cells in vitro and in vivo. Am J Respir Cell Mol Biol 2000;23:626-635.
28. Atabai K., Ishigaki M., Geiser T., Ueki I., Matthay M.A., Ware L.B. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am J Physiol Lung Cell Mol Physiol 2002;283:L163-L169. (Pubitemid 34764553)
29. Johansson J., Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 1997;244:675-693. (Pubitemid 27130502)